Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep;181(3):438.
doi: 10.1111/bjd.18251. Epub 2019 Jul 28.

Predicting treatment success with biologics in psoriasis

J M P A van den Reek  1
Affiliations
Comment

Predicting treatment success with biologics in psoriasis

J M P A van den Reek. Br J Dermatol. 2019 Sep.

Abstract

Linked Article: https://doi.org/10.1111/bjd.17738.

PubMed Disclaimer

Conflict of interest statement

J.M.P.A.v.d.R. carries out clinical trials for AbbVie, Celgene and Janssen and has received speaking fees from AbbVie and Janssen and reimbursement for attending a symposium from Celgene and AbbVie. All funding is not personal but goes to the independent research fund of the Department of Dermatology of Radboud University Medical Centre Nijmegen, the Netherlands.

Comment on

References

    1. Lin PT, Wang SH, Chi CC. Drug survival of biologics in treating psoriasis: a meta‐analysis of real‐world evidence. Sci Rep 2018; 8:16068. - PMC - PubMed
    1. van den Reek J, Kievit W, Gniadecki R et al Drug survival studies in dermatology: principles, purposes, and pitfalls. J Invest Dermatol 2015; 135:1–5. - PubMed
    1. Mourad A, Straube S, Armijo‐Olivo S, Gniadecki R. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta‐analysis. Br J Dermatol 2019; 181:450–58. - PubMed